Annexon Inc.

12/16/2024 | Press release | Distributed by Public on 12/16/2024 06:30

Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.